Undertaking community engagement for a controlled human malaria infection study in Kenya: approaches and lessons learnt by Mumba, N, Njuguna, P, Chi, P, Marsh, V, Awuor, E, Hamaluba, M, Mauncho, C, Mwalukore, S, Masha, J, Mwangoma, M, Kalama, B, Alphan, H, Wambua, J, Bejon, P, Kamuya, D, Kapulu, MC

Safety and immunogenicity of ChAdOx1 nCoV-19 (AZD1222) vaccine in adults in Kenya: a phase 1/2 single-blind, randomised controlled trial by Hamaluba, M, Sang, S, Orindi, B, Njau, I, Karanja, H, Kamau, N, Gitonga, J, Mugo, D, Wright, D, Nyagwange, J, Kutima, B, Omuoyo, D, Mwatasa, M, Ngetsa, C, Agoti, C, Cheruiyot, S, Nyaguara, A, Munene, M, Mturi, N, Oloo, E, Ochola-Oyier, L, Mumba, N, Mauncho, C, Namayi, R, Davies, A, Tsofa, B, Nduati, E, Aliyan, N, Kasera, K, Etyang, A, Boyd, A, Hill, A, Gilbert, S, Douglas, A, Pollard, A, Bejon, P, Lambe, T, Warimwe, G